Zeincro was established in 1998 and currently is positioned as a leading provider in more than 21 European countries with access to> 365 MN population.
With all most 20 years of experience in successful clinical research projects, more than 220 employees ZEINCRO workforce have developed a thorough understanding of the communities and the regions in which it operates. We have established strong professional relations with local healthcare stakeholders. This approach allows ZEINCRO to set new standards for successful clinical trials by delivering bespoke services that are flexible, ethical and maximize patient recruitment and compliance. ZEINCRO combines the advantages of a CRO with local presence and local expertise. Its business success is based on reliable partnerships and thus contributes to its long-term repeated business.
ZEINCRO provides clinical trial services to the global drug development industry and offers additional services in the areas of post-marketing safety and efficacy studies, regulatory affairs and pharmacovigilance (IRISG) , Phase I studies, including risk management plans. With more than 250 clients worldwide, resulting in more than 40 long-term, ongoing collaborations. Among our customers are multinational and local pharmaceutical companies, global CROs, biotechnology and medical device companies as well as medical associations.